Chemkart India Reports Strong H1 FY27 Growth Driven by Robust Operating Demand
Chemkart India Ltd 路 Investor Presentation 路 31 Oct 2026, 3:16 am
Chemkart India Reports Strong H1 FY27 Growth Driven by Robust Operating Demand Chemkart India reported robust consolidated performance for H1 FY27 ended 30th Sep'26, with revenue from operations surging 99.4% YoY to INR 20,587.3 lacs. EBITDA grew 107.5% YoY to INR 2,937.0 lacs as EBITDA margins expanded 60 bps to 14.3%. Profit after tax climbed 122.2% YoY to INR 2,255.9 lacs, with PAT margin expanding 120 bps to 11.0% and EPS reaching INR 18.65. Growth was driven by amino acids (50.0% of revenue) and sports nutrition (28.8%). Construction continues on its JNPA SEZ CDMO greenfield facility.
Original exchange filing (PDF)
More announcements from Chemkart India Ltd
- Disclosure for Acquistion of Equity Shares of Subsidiary Company under the Rights Issue. 路 17 Nov 2026
- Monitoring Agency Report for the Quarter ended 30th September 2026. 路 12 Nov 2026
- Regulation 32 Statement for the Half Year ended 30th September 2026. 路 31 Oct 2026
- Financial Results for the Half Year ended 30th September 2026. 路 31 Oct 2026
- Outcome of Board Meeting dated 30th October 2026. 路 31 Oct 2026
- Disclosure for Acquisition of Equity Shares of Wholly-Owned Subsidiary Company under the Rights Issue. 路 27 Oct 2026
- Chemkart India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve 1. Un-Audited Standalone and .... 路 30 Oct 2026
- We are submitting herewith Disclosure for Change in CIN of the Company on Corporate Information Page on BSE Limited. 路 14 Oct 2026
